Epigenetic signaling axis regulates proliferation and self-renewal of neural stem/progenitor cells

June 14, 2017, Chinese Academy of Sciences
Mechanism of the EZH2-miR-203-BMI1 regulatory axis in proliferation and differentiation of NSPCs. Credit: LIU Changmei

Polycomb group (PcG) proteins comprise the polycomb complexes PRC1 and PRC2 that regulate gene expression levels through histone modification. Although PRC1 and PRC2 have important roles in cancer stem cells, their functions in neural stem/progenitor cells (NSPCs) are largely unknown.

In a recent study published in Stem Cell Reports, a team led by Drs. LIU Changmei and TENG Zhaoqian of the Chinese Academy of Sciences found a novel epigenetic signaling axis (composed of PRC1, microRNA, and PRC2) that regulates self-renewal and proliferation of NSPCs. The researchers generated an Ezh2 (a key PRC2 component) conditional knockout mouse model, and found that Ezh2 loss of function results in decreased self-renewal and proliferation ability in NSPCs.

They discovered that Ezh2 represses the expression of miR-203, which negatively regulates self-renewal and proliferation of NSPCs, but promotes their neuronal differentiation capacity. In addition, they demonstrated that Bmi1 (a PRC1 component) is a direct downstream target of miR-203, and ectopic overexpression of BMI1 can rescue the self-renewal and deficiency exhibited by miR-203 overexpression in NSPCs.

As PcG proteins and microRNAs are usually co-expressed, these findings might have significant implications for other cell types or cancer tissues.

Explore further: The paradoxical roles of well-known cancer genes are mediated by oxygen levels in breast cancer

More information: Pei-Pei Liu et al, MiR-203 Interplays with Polycomb Repressive Complexes to Regulate the Proliferation of Neural Stem/Progenitor Cells, Stem Cell Reports (2017). DOI: 10.1016/j.stemcr.2017.05.007

Related Stories

The paradoxical roles of well-known cancer genes are mediated by oxygen levels in breast cancer

January 4, 2017
Oxygen deprivation, or hypoxia, has been identified by A*STAR researchers as a key factor in switching the function of major cancer genes from tumor-promoting to tumor-suppressing in a breast cancer subtype, suggesting the ...

Controlling cell-fate decisions

September 23, 2016
Rafal Ciosk and his group at the FMI have identified an important link between the Notch signaling pathway and PRC2-mediated gene silencing. They showed that a fine balance between epigenetic silencing and signaling is crucial ...

Study pinpoints driver, potential target in aggressive pediatric leukemia subtype

February 18, 2016
A University of Colorado Cancer Center study scheduled for Feb. 18, 2016 online publication in the journal Cell Reports models Early T-Cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL), discovering inactivation of the ...

Recommended for you

New therapeutic gel shows promise against cancerous tumors

February 21, 2018
Scientists at the UNC School of Medicine and NC State have created an injectable gel-like scaffold that can hold combination chemo-immunotherapeutic drugs and deliver them locally to tumors in a sequential manner. The results ...

Kinase inhibitor larotrectinib shows durable anti-tumor abilities

February 21, 2018
Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses. All patients had tumors ...

Five novel genetic changes linked to pancreatic cancer risk

February 21, 2018
In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other ...

Similarities found in cancer initiation in kidney, liver, stomach, pancreas

February 21, 2018
Recent research at Washington University School of Medicine in St. Louis demonstrated that mature cells in the stomach sometimes revert back to behaving like rapidly dividing stem cells. Now, the researchers have found that ...

Research could change how doctors treat leukemia and other cancers fed by fat

February 21, 2018
Obesity and cancer risk have a mysterious relationship, with obesity increasing the risk for 13 types of cancer. For some cancers—including pediatric cancers—obesity affects survival rates, which are lower for people ...

New technique predicts gene resistance to cancer treatments

February 21, 2018
Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.